John M. Baust, Ph.D.

Founder / Scientific Advisor

Therapeutic Areas

Drug	Indication	Phase
SereneRF for Soft Tissue Tumors	Pancreatic Cancer / Solid Tumors	Early Clinical
SereneRF for Cardiac Arrhythmias	Ventricular Tachycardia	Pre-clinical / Early Clinical